381 related articles for article (PubMed ID: 20361945)
1. Notch signaling: emerging molecular targets for cancer therapy.
Yin L; Velazquez OC; Liu ZJ
Biochem Pharmacol; 2010 Sep; 80(5):690-701. PubMed ID: 20361945
[TBL] [Abstract][Full Text] [Related]
2. Targeting Notch signaling for cancer therapeutic intervention.
Shao H; Huang Q; Liu ZJ
Adv Pharmacol; 2012; 65():191-234. PubMed ID: 22959027
[TBL] [Abstract][Full Text] [Related]
3. Exploitation of the Notch signaling pathway as a novel target for cancer therapy.
Wang Z; Li Y; Banerjee S; Sarkar FH
Anticancer Res; 2008; 28(6A):3621-30. PubMed ID: 19189643
[TBL] [Abstract][Full Text] [Related]
4. Rational targeting of Notch signaling in cancer.
Rizzo P; Osipo C; Foreman K; Golde T; Osborne B; Miele L
Oncogene; 2008 Sep; 27(38):5124-31. PubMed ID: 18758481
[TBL] [Abstract][Full Text] [Related]
5. Targeting notch to eradicate pancreatic cancer stem cells for cancer therapy.
Wang Z; Ahmad A; Li Y; Azmi AS; Miele L; Sarkar FH
Anticancer Res; 2011 Apr; 31(4):1105-13. PubMed ID: 21508353
[TBL] [Abstract][Full Text] [Related]
6. Notch signaling in solid tumors.
Koch U; Radtke F
Curr Top Dev Biol; 2010; 92():411-55. PubMed ID: 20816403
[TBL] [Abstract][Full Text] [Related]
7. Notch signaling in the hematopoietic system.
Sandy AR; Maillard I
Expert Opin Biol Ther; 2009 Nov; 9(11):1383-98. PubMed ID: 19743891
[TBL] [Abstract][Full Text] [Related]
8. The Hedgehog pathway as a drug target in cancer therapy.
Lauth M; Toftgård R
Curr Opin Investig Drugs; 2007 Jun; 8(6):457-61. PubMed ID: 17621875
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of Notch pathway by a gamma-secretase inhibitor attenuates AKT/mammalian target of rapamycin signaling and glucose uptake in an ERBB2 transgenic breast cancer model.
Efferson CL; Winkelmann CT; Ware C; Sullivan T; Giampaoli S; Tammam J; Patel S; Mesiti G; Reilly JF; Gibson RE; Buser C; Yeatman T; Coppola D; Winter C; Clark EA; Draetta GF; Strack PR; Majumder PK
Cancer Res; 2010 Mar; 70(6):2476-84. PubMed ID: 20197467
[TBL] [Abstract][Full Text] [Related]
10. The Hedgehog signalling pathway as a therapeutic target in early breast cancer development.
O'Toole SA; Swarbrick A; Sutherland RL
Expert Opin Ther Targets; 2009 Sep; 13(9):1095-103. PubMed ID: 19659449
[TBL] [Abstract][Full Text] [Related]
11. Interplay between Notch signaling and epigenetic silencers in cancer.
Dominguez M
Cancer Res; 2006 Sep; 66(18):8931-4. PubMed ID: 16982729
[TBL] [Abstract][Full Text] [Related]
12. Notch regulation of tumor angiogenesis.
Bridges E; Oon CE; Harris A
Future Oncol; 2011 Apr; 7(4):569-88. PubMed ID: 21463145
[TBL] [Abstract][Full Text] [Related]
13. Targeting the Notch signaling pathway in autoimmune diseases.
Ma D; Zhu Y; Ji C; Hou M
Expert Opin Ther Targets; 2010 May; 14(5):553-65. PubMed ID: 20334488
[TBL] [Abstract][Full Text] [Related]
14. The Notch pathway in prostate development and cancer.
Leong KG; Gao WQ
Differentiation; 2008 Jul; 76(6):699-716. PubMed ID: 18565101
[TBL] [Abstract][Full Text] [Related]
15. Targeting Notch signaling in pancreatic cancer.
Ristorcelli E; Lombardo D
Expert Opin Ther Targets; 2010 May; 14(5):541-52. PubMed ID: 20392166
[TBL] [Abstract][Full Text] [Related]
16. Notch signaling as a therapeutic target in cancer: a new approach to the development of cell fate modifying agents.
Nickoloff BJ; Osborne BA; Miele L
Oncogene; 2003 Sep; 22(42):6598-608. PubMed ID: 14528285
[TBL] [Abstract][Full Text] [Related]
17. Lasting longer without oxygen: The influence of hypoxia on Notch signaling.
Pear WS; Simon MC
Cancer Cell; 2005 Dec; 8(6):435-7. PubMed ID: 16338655
[TBL] [Abstract][Full Text] [Related]
18. Modulating Notch signaling by pathway-intrinsic and pathway-extrinsic mechanisms.
Poellinger L; Lendahl U
Curr Opin Genet Dev; 2008 Oct; 18(5):449-54. PubMed ID: 18722525
[TBL] [Abstract][Full Text] [Related]
19. NUMB is a break of WNT-Notch signaling cycle.
Katoh M; Katoh M
Int J Mol Med; 2006 Sep; 18(3):517-21. PubMed ID: 16865239
[TBL] [Abstract][Full Text] [Related]
20. Notch pathway as candidate therapeutic target in Her2/Neu/ErbB2 receptor-negative breast tumors.
Hirose H; Ishii H; Mimori K; Ohta D; Ohkuma M; Tsujii H; Saito T; Sekimoto M; Doki Y; Mori M
Oncol Rep; 2010 Jan; 23(1):35-43. PubMed ID: 19956862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
